Perspective · 10 Sep 2026
Conference abstractPublished 21 Jul 2016
Signaling cascades regulating natural killer cell activation threshold
Bar-Ilan University, Israel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Natural killer (NK) cells represent a powerful weapon of immune defense against viral infections and tumor growth via the cytotoxicity of target cells and the production of cytokines. NK cell function is regulated by a balance between activating and inhibitory signals. Cancer cells or viruses often perturb this balance by expressing ligands for activating NK cell receptors and by down-regulating ligands for the inhibitory receptors, i.e., MHC class I molecules, resulting in target cell killing. Engagement of inhibitory receptors, including the killer cell immunoglobulin-like receptor (KIR), antagonizes activating pathways through the recruitment and activation of the SH2-containing protein tyrosine phosphatase-1 (SHP-1) to the NK immunological synapse (NKIS). To date, only the signaling molecule VAV1 was clearly demonstrated as a direct substrate of SHP-1 in human NK cells. Since SHP-1 activity is the major mechanism that prevents NK cell autoimmune response, it is of great importance to determine whether additional substrates of SHP-1 exist and whether additional molecular mechanisms down-regulate NK cell activation. Moreover, the mechanisms that control SHP-1 activity remain to be unraveled. In the present study, we demonstrate that in response to KIR receptor engagement, SHP-1 and the E3 ubiquitin ligases Cbls negatively regulate the linker for the activation of T cells (LAT) and phospholipase CÃ?Â?Ã?³ (PLCÃ?Â?Ã?³) 1/2. LAT dephosphorylation by SHP-1 abrogated PLCÃ?Â?Ã?³ 1/2 recruitment to NKIS and decreased calcium flux and degranulation, thus abolishing NK cell cytotoxicity. Furthermore, LAT ubiquitylation via c-Cbl and Cbl-b following NK cell inhibition leads to its degradation and to the downregulation of NK cell activation. Using a cutting-edge microscope system, we follow this cellular signaling cascade from the moment of encounter through target-cell killing. Our data suggest that LAT phosphorylation triggers its ubiquitylation, implying a collateral inhibitory mechanism in which a pool of phosphorylated LAT that escapes SHP-1 dephosphorylation is targeted to proteasomal degradation. These mechanisms serve as a key checkpoint in tuning NK cell activation threshold and the immune response.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Mira Barda-Saad”
- BylineArticles whose byline prints “Omri Matalon”
- BylineArticles whose byline prints “Aviad Ben-Shmuel”
- BylineArticles whose byline prints “Sophia Fried”

